(Q36727470)

15 August 2017

1 reference

title

In search of effective anti-HHV-6 agents (English)

1 reference

15 August 2017

Lieve Naesens

2

0 references

Erik De Clercq

object named as

Erik De Clercq

series ordinal

1

0 references

publication date

1 December 2006

1 reference

Journal of Clinical Virology

15 August 2017

1 reference

15 August 2017

37 Suppl 1

1 reference

15 August 2017

S82-6

1 reference

Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

A novel selective broad-spectrum anti-DNA virus agent

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Antiviral potential of a new generation of acyclic nucleoside phosphonates, the 6-[2-(phosphonomethoxy)alkoxy]-2,4-diaminopyrimidines

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Antiviral properties of new arylsulfone derivatives with activity against human betaherpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

Design and development of oral drugs for the prophylaxis and treatment of smallpox infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

2-Chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide (CMV423), a new lead compound for the treatment of human cytomegalovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2806%2970017-8

7 January 2021

10.1016/S1386-6532(06)70017-8

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17276375